ReviewCancers2025

Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications.

Ante S Lundberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.